PHASE-II TRIAL OF DOXORUBICIN IN BIDIMENSIONALLY MEASURABLE PROSTATIC ADENOCARCINOMA

被引：44

作者：

SCHER, H

YAGODA, A

WATSON, RC

SERBER, M

WHITMORE, W

机构：

[1] MEM SLOAN KETTERING CANC CTR,DEPT MED,SOLID TUMOR SERV,NEW YORK,NY 10021

[2] MEM SLOAN KETTERING CANC CTR,DEPT DIAGNOST RADIOL,NEW YORK,NY 10021

[3] MEM SLOAN KETTERING CANC CTR,DEPT SURG,UROL SERV,NEW YORK,NY 10021

来源：

关键词：

D O I：

10.1016/S0022-5347(17)50829-0

中图分类号：

R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：1099 / 1102

页数：4

共 23 条

[1] BERRY WR, 1979, CANCER, V44, P763, DOI 10.1002/1097-0142(197908)44:2<763::AID-CNCR2820440251>3.0.CO
[2] 2-5
[3] SYSTEMIC TREATMENT OF ADVANCED PROSTATIC-CANCER - DEVELOPMENT OF A NEW SYSTEM FOR DEFINING RESPONSE
CITRIN, DL
COHEN, AI
HARBERG, J
SCHLISE, S
HOUGEN, C
BENSON, R
[J]. JOURNAL OF UROLOGY, 1981, 125 (02) : 224 - 227
[4] DEWYS W, 1978, P AM ASS CANCER RES, V19, P338
[5] A COMPARATIVE CLINICAL-TRIAL OF ADRIAMYCIN AND 5-FLUOROURACIL IN ADVANCED PROSTATIC-CANCER - PROGNOSTIC FACTORS AND RESPONSE
DEWYS, WD
BEGG, CB
BRODOVSKY, H
CREECH, R
KHANDEKAR, J
[J]. PROSTATE, 1983, 4 (01) : 1 - 11
[6] EAGAN RT, 1976, CANCER TREAT REP, V60, P115
[7] IHDE DC, 1980, CANCER, V45, P1300, DOI 10.1002/1097-0142(19800315)45:6<1300::AID-CNCR2820450606>3.0.CO
[8] 2-0
[9] OBRYAN RM, 1973, CANCER-AM CANCER SOC, V32, P1, DOI 10.1002/1097-0142(197307)32:1<1::AID-CNCR2820320101>3.0.CO
[10] 2-X